Growth Metrics

Alnylam Pharmaceuticals (ALNY) EBITDA Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 12,615.00
Dec 31, 2025 16,315.00
Sep 30, 2025 22,518.00
Jun 30, 2025 16,592.00
Mar 31, 2025 10,787.00
Dec 31, 2024 37,254.00
Sep 30, 2024 27,525.00
Jun 30, 2024 49,380.00
Mar 31, 2024 53,124.00
Dec 31, 2023 97,512.00
Sep 30, 2023 1.19 Mn
Jun 30, 2023 45,744.00
Mar 31, 2023 59,396.00
Dec 31, 2022 31,466.00
Sep 30, 2022 56,365.00
Jun 30, 2022 61,887.00
Mar 31, 2022 45,296.00
Dec 31, 2021 57,989.00
Sep 30, 2021 65,056.00
Jun 30, 2021 117,067.00
Mar 31, 2021 147,522.00
Dec 31, 2020 89,515.00
Sep 30, 2020 142,070.00
Jun 30, 2020 104,015.00
Mar 31, 2020 7,568.00
Dec 31, 2019 -43,904.00
Sep 30, 2019 16,731.00
Jun 30, 2019 14,842.00
Mar 31, 2019 242,303.00
Dec 31, 2018 -63,744.00
Sep 30, 2018 -1.15 Mn
Jun 30, 2018 -41,838.00
Mar 31, 2018 -62,609.00
Dec 31, 2017 17,210.00
Sep 30, 2017 -60,247.00
Jun 30, 2017 -68,195.00
Mar 31, 2017 -51,332.00
Dec 31, 2016 -60,949.00
Sep 30, 2016 -69,536.00
Jun 30, 2016 -118,817.00
Mar 31, 2016 -150,269.00
Dec 31, 2015 -101,257.00
Sep 30, 2015 -159,033.00
Jun 30, 2015 -116,042.00
Mar 31, 2015 -20,465.00
Dec 31, 2014 8,441.00
Sep 30, 2014 -42,600.00
Jun 30, 2014 -55,771.00